- Home
- GLP vs IRON Comparison
GLP vs IRON Comparison
Compare GLP & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLP
- IRON
- Stock Information
- Founded
- GLP 2005
- IRON 2017
- Country
- GLP United States
- IRON United States
- Employees
- GLP N/A
- IRON N/A
- Industry
- GLP Oil Refining/Marketing
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- GLP Energy
- IRON Health Care
- Exchange
- GLP Nasdaq
- IRON Nasdaq
- Market Cap
- GLP 1.8B
- IRON 1.8B
- IPO Year
- GLP 2005
- IRON N/A
- Fundamental
- Price
- GLP $51.64
- IRON $51.99
- Analyst Decision
- GLP Hold
- IRON Strong Buy
- Analyst Count
- GLP 1
- IRON 10
- Target Price
- GLP $56.00
- IRON $93.40
- AVG Volume (30 Days)
- GLP 75.2K
- IRON 411.3K
- Earning Date
- GLP 08-06-2025
- IRON 08-07-2025
- Dividend Yield
- GLP 5.79%
- IRON N/A
- EPS Growth
- GLP 16.18
- IRON N/A
- EPS
- GLP 3.13
- IRON N/A
- Revenue
- GLP $17,610,371,000.00
- IRON N/A
- Revenue This Year
- GLP $38.58
- IRON N/A
- Revenue Next Year
- GLP $17.34
- IRON N/A
- P/E Ratio
- GLP $16.45
- IRON N/A
- Revenue Growth
- GLP 6.04
- IRON N/A
- 52 Week Low
- GLP $37.00
- IRON $30.82
- 52 Week High
- GLP $60.00
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- GLP 44.56
- IRON 53.12
- Support Level
- GLP $51.02
- IRON $51.01
- Resistance Level
- GLP $53.50
- IRON $55.52
- Average True Range (ATR)
- GLP 1.87
- IRON 2.42
- MACD
- GLP -0.42
- IRON -0.18
- Stochastic Oscillator
- GLP 11.29
- IRON 46.84
About GLP Global Partners LP Common Units representing Limited Partner Interests
Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.